Medicare Enrolled
Dr. Luis Barreras, M.D., FACP
Hematology & Oncology · Ft Lauderdale, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barreras from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barreras?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barreras
Dr. Luis Barreras is a hematology & oncology specialist in Ft Lauderdale, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Barreras performed 4,870 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Barreras received a total of $21,574 from 84 pharmaceutical and/or device companies across 969 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barreras is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 29% volume in FL
$21,574 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,870
Medicare services
Top 29% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,858 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 1,048 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
478 | $8 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
427 | $96 | $272 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
205 | $65 | $196 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
158 | $8 | $16 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
126 | $103 | $297 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
97 | $11 | $30 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
65 | $1 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
63 | $22 | $63 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
63 | $72 | $140 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
57 | $49 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $131 | $344 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
38 | $15 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $141 | $336 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
35 | $12 | $36 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
30 | $107 | $272 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $43 | $123 |
| New patient office visit, complex (60-74 min) | 11 | $180 | $461 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.8% high complexity
63.7% medium
30.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,574
Total received (2018-2024)
Avg $3,082/year across 7 years
Top 25% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
969
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,348
2023
$3,777
2022
$3,226
2021
$3,974
2020
$1,647
2019
$2,430
2018
$2,172
Payments by company (2024)
PFIZER INC.
$476
AstraZeneca Pharmaceuticals LP
$323
Janssen Biotech, Inc.
$274
Merck Sharp & Dohme LLC
$259
GlaxoSmithKline, LLC.
$218
Adaptive Biotechnologies Corporation
$200
E.R. Squibb & Sons, L.L.C.
$190
Eisai Inc.
$146
Novartis Pharmaceuticals Corporation
$131
Regeneron Healthcare Solutions, Inc.
$122
SOBI, INC
$115
Rigel Pharmaceuticals, Inc.
$110
ABBVIE INC.
$103
Takeda Pharmaceuticals U.S.A., Inc.
$99
Genentech USA, Inc.
$98
Coherus Biosciences Inc.
$93
Celgene Corporation
$86
Lilly USA, LLC
$86
Daiichi Sankyo Inc.
$85
EMD Serono, Inc.
$81
Pharmacosmos Therapeutics Inc.
$73
Astellas Pharma US Inc
$68
ARRAY BIOPHARMA INC
$68
Bayer Healthcare Pharmaceuticals Inc.
$67
Karyopharm Therapeutics Inc.
$62
BeiGene USA, Inc.
$58
Incyte Corporation
$58
Alexion Pharmaceuticals, Inc.
$55
RECORDATI_RARE_DISEASES_INC.
$50
TAIHO ONCOLOGY, INC.
$49
Blueprint Medicines Corporation
$48
PUMA BIOTECHNOLOGY, INC.
$35
Legend Biotech USA Inc.
$33
Aveo Pharmaceuticals, Inc.
$26
Kyowa Kirin, Inc.
$25
Biocon Biologics Inc
$24
ACCORD HEALTHCARE, INC.
$24
SERVIER PHARMACEUTICALS LLC
$24
Azurity Pharmaceuticals, Inc.
$24
Sumitomo Pharma America, Inc.
$23
Ipsen Biopharmaceuticals, Inc
$23
Blue Earth Diagnostics Limited
$22
Geron Corporation
$22
Octapharma USA, Inc.
$21
ADC Therapeutics America, Inc.
$21
Janssen Pharmaceuticals, Inc
$20
GENZYME CORPORATION
$20
JAZZ PHARMACEUTICALS INC.
$14
Top 3 companies account for 24.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,423
AstraZeneca Pharmaceuticals LP
$2,184
PFIZER INC.
$1,601
Janssen Biotech, Inc.
$1,158
E.R. Squibb & Sons, L.L.C.
$917
Rigel Pharmaceuticals, Inc.
$887
Celgene Corporation
$713
Merck Sharp & Dohme LLC
$659
Eisai Inc.
$601
Genentech USA, Inc.
$596
Merck Sharp & Dohme Corporation
$574
Incyte Corporation
$532
Lilly USA, LLC
$471
Astellas Pharma US Inc
$460
Seagen Inc.
$418
GENZYME CORPORATION
$358
GlaxoSmithKline, LLC.
$351
Amgen Inc.
$325
Takeda Pharmaceuticals U.S.A., Inc.
$321
EMD Serono, Inc.
$253
Adaptive Biotechnologies Corporation
$238
Dova Pharmaceuticals
$222
JAZZ PHARMACEUTICALS INC.
$220
EISAI INC.
$220
Bayer HealthCare Pharmaceuticals Inc.
$213
BeiGene USA, Inc.
$207
Regeneron Healthcare Solutions, Inc.
$189
INSYS Therapeutics Inc
$188
ARRAY BIOPHARMA INC
$187
Pharmacosmos Therapeutics Inc.
$183
ABBVIE INC.
$172
SOBI, INC
$170
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Daiichi Sankyo Inc.
$166
Karyopharm Therapeutics Inc.
$160
Sobi, Inc
$160
Kyowa Kirin, Inc.
$152
Coherus Biosciences Inc.
$138
Ipsen Biopharmaceuticals, Inc
$130
PUMA BIOTECHNOLOGY, INC.
$129
Novocure Inc.
$124
AbbVie Inc.
$121
TAIHO ONCOLOGY, INC.
$120
Exelixis Inc.
$119
Bayer Healthcare Pharmaceuticals Inc.
$115
SERVIER PHARMACEUTICALS LLC
$95
MEDIVATION FIELD SOLUTIONS LLC
$85
Foundation Medicine, Inc.
$81
Alexion Pharmaceuticals, Inc.
$72
Deciphera Pharmaceuticals Inc.
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
AbbVie, Inc.
$63
Taiho Oncology, Inc.
$62
Janssen Pharmaceuticals, Inc
$56
Alnylam Pharmaceuticals Inc.
$54
Jazz Pharmaceuticals Inc.
$50
RECORDATI_RARE_DISEASES_INC.
$50
Blueprint Medicines Corporation
$48
Apellis Pharmaceuticals, Inc.
$47
Octapharma USA, Inc.
$46
Mirati Therapeutics, Inc.
$43
Myriad Genetic Laboratories, Inc.
$43
Gilead Sciences, Inc.
$40
Acceleron Pharma, Inc.
$37
Global Blood Therapeutics, Inc.
$35
Legend Biotech USA Inc.
$33
Amneal Pharmaceuticals LLC
$33
Agios Pharmaceuticals, Inc.
$32
Aveo Pharmaceuticals, Inc.
$26
Biocon Biologics Inc
$24
ACCORD HEALTHCARE, INC.
$24
Azurity Pharmaceuticals, Inc.
$24
Sumitomo Pharma America, Inc.
$23
TerSera Therapeutics LLC
$22
Blue Earth Diagnostics Limited
$22
Geron Corporation
$22
Emmaus Medical, Inc.
$21
ADC Therapeutics America, Inc.
$21
Puma Biotechnology, Inc.
$20
Teva Pharmaceuticals USA, Inc.
$18
Advanced Accelerator Applications
$17
Acrotech Biopharma Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$14
Organon LLC
$9
Top 3 companies account for 28.8% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CERDELGA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Empaveli · Endari · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Oncology · Onivyde · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYTELO · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUBSYS · SUTENT · SYLVANT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
112
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
HOLY CROSS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barreras is a clinical cardiology specialist, with above-average Medicare volume (top 29% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barreras experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Barreras performed 1,858 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Barreras receive payments from pharmaceutical companies?
Yes. Dr. Barreras received a total of $21,574 from 84 companies across 969 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barreras's costs compare to other hematology & oncology specialists in Ft Lauderdale?
Dr. Barreras's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barreras) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Ft Lauderdale
Browse hematology & oncology specialists in Ft Lauderdale ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology